Oban BioPharma
Overview
Oban Biopharma leads AI-powered allosteric GPCR therapeutic development for metabolic and CNS diseases, advancing next-generation precision medicines.
Related on NestLens
Last updated July 15, 2026
Oban Biopharma leads AI-powered allosteric GPCR therapeutic development for metabolic and CNS diseases, advancing next-generation precision medicines.
Last updated July 15, 2026